Related Experiment Video
Updated: Jun 5, 2025

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
Recognition and management of treatment-resistant depression
1Cyrus Ma practices in psychiatry at Clarity Clinic in Chicago, Ill. Brittany Strelow practices in community internal medicine, geriatrics, and palliative medicine at Mayo Clinic in Rochester, Minn. The authors have disclosed no potential conflicts of interest, financial or otherwise.
Abstract:
Major depressive disorder (MDD) is a common psychiatric condition that causes considerable morbidity and disability. MDD is characterized by recurrent depressive episodes that can result in loss of productivity, job insecurity, social isolation, and suicidality. Primary care providers frequently provide the initial management of MDD; however, some patients do not respond to first- or second-line treatments, a condition called treatment-resistant depression (TRD). Understanding how to accurately diagnose and manage TRD is important for clinicians.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Antidepressant Drugs: MAOIs and Other Agents
Drug Therapy
Antianxiety Medications
Antidepressant Drugs: Overview
Electroconvulsive Therapy
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

